Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT01309529 Recruiting - Clinical trials for Postoperative Urinary Tract Infection

Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients

Start date: March 2011
Phase: N/A
Study type: Observational

Current standard of practice in study institution dictates day of surgery urinary catheter removal in general thoracic surgery patients receiving thoracic epidural analgesia. The investigators hypothesize that this practice results in low recatheterization rates secondary to urinary retention and low urinary tract infection rates.

NCT ID: NCT01304459 Recruiting - Infection Clinical Trials

Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care

Start date: January 2011
Phase: N/A
Study type: Observational

Observational protocol to analyse routine vancomycin serum levels of patients under intensive care and to obtain percentage of patients that achieve therapeutic values.

NCT ID: NCT01248598 Recruiting - Clinical trials for Epstein-Barr Virus Infections

The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

Start date: October 2010
Phase: N/A
Study type: Observational

The purpose of this study is to study the prevalence of EBV, HCMV, HHV-6 in saliva and on the toothbrush patient with periodontitis.

NCT ID: NCT01237730 Recruiting - Clinical trials for Prophylactic Antibiotics Before PEG

Tailored Antibiotics Prophylaxis for Percutaneous Endoscopic Gastrostomy

PEG
Start date: July 2010
Phase: N/A
Study type: Interventional

Tailored antibiotic prophylaxis according to the individual throat swab culture could reduce the peristomal infection rate

NCT ID: NCT01225770 Recruiting - Influenza Infection Clinical Trials

Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers

Start date: November 2010
Phase: Phase 3
Study type: Interventional

Experimental and clinical studies in adults have reported that green tea catechins prevent influenza infection. In this clinical randomized study, the investigators aimed to determine the effects of gargling with green tea on the prophylaxis of influenza infection among high school teenagers.

NCT ID: NCT01215604 Recruiting - Infection Clinical Trials

Involvement of Translation Initiation Factors in the Immune Response in the Elderly

Start date: October 2010
Phase: N/A
Study type: Observational

The investigators propose that the translation initiation factors eIF4E and eIF4GI may be involved in resolution of acute inflammation (regardless of age). Furthermore, the investigators suggest that differences in translation initiation factors state of activation may contribute to inflammation. Finally, the investigators hypothesize that differences in translation initiation factors state of activation may underlie the immune compromised state of the very elderly affording additional explanation for the heightened morbidity from infection in this group. In the current study the investigators aim to test these hypotheses by measuring the levels of eIF4E and eIF4G, their regulators, and targets in elderly (65-84yrs) and very elderly (85yrs<) patients hospitalized at Meir hospital for acute infection and after their recovery (detailed in study design).

NCT ID: NCT01173068 Recruiting - Clinical trials for Urinary Tract Infections

An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.

Start date: August 2010
Phase: N/A
Study type: Observational

The aim of this study is to determine the outcomes when using ertapenem for complicated urinary tract infections in the OPAt setting. The study hypothesis: Ertapenem is an efficacious and safe therapeutic option for complicated urinary tract infections in the OPAt setting.

NCT ID: NCT01142934 Recruiting - Infection Clinical Trials

Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections

TegaCHG
Start date: October 2009
Phase: Phase 4
Study type: Interventional

TegaCHG is a multicentric randomized study aimed at evaluating the possibility that the use of TegaDerm CHG dressing may reduce the incidence of catheter related blood stream infections (CRBSI). It implies the comparison between the incidence of CRBSI in patients with central venous catheter dressed with TegaDerm without chlorhexidine gluconate (CHG) and with CHG. The primary endpoint is the occurrence of CRBSI and the secondary endpoints are: catheter colonization (growth of microbes from the culture of catheter tip, > 15 CFU according to semi-quantitative method or > 1000 CFU according to quantitative method); incidence of catheter exit site infection; occurrence of catheter related infections/sepsis or other severe infection-related complications; safety profile evaluation: occurrence of hypersensitivity to the dressing on the basis of local objectivity (erythema, edema, other) or on that of patient symptoms (itch, burning sensation); relating to the device performance: incidence of high/medium/low dressing edge lift, ability to visualize the catheter insertion site, easiness of removal, easiness of dressing application; incidence of unscheduled dressing change. The study hypothesis implies that the use of slow release device containing chlorhexidine may decrease the incidence of CRBSI. This has already been showed for chlorhexidine impregnated sponges. Scope of the study is to verify if this property is also true for TegaDerm CHG,which is a new chlorhexidine-releasing dressing in which the medication is directly released by an integrated transparent gel pad, so that the catheter exit site remains visible and easy to inspect without removing the dressing.

NCT ID: NCT01142882 Recruiting - HIV Infections Clinical Trials

Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention

Start date: February 2010
Phase: N/A
Study type: Interventional

This study will evaluate the comparative effectiveness and cost-effectiveness of a customized, interactive web-based HIV, sexually transmitted infections (STI) and hepatitis prevention intervention as compared to a traditional, educator-delivered prevention intervention. Both interventions will be offered to youth enrolled in outpatient, community-based substance abuse treatment at our collaborating treatment facilities. Outcomes to be measured include accurate HIV/disease prevention knowledge, intentions to engage in safer sex, actual HIV risk behavior, attitudes toward safer sex and self-reported substance use. The web-delivered intervention under evaluation has the potential to deliver evidence-based content at low cost without increasing demands on treatment staff time or training needs.

NCT ID: NCT01137942 Recruiting - Clinical trials for Persistence of Infection With Helicobacter Pylori

The Role of Cathepsin X in Infection With the Helicobacter Pylori

Start date: November 2008
Phase: N/A
Study type: Observational

The immune response to Helicobacter pylori (Hp) importantly determines the pathogenesis of infection as well as the success of antibiotic eradication of the bacteria. The investigators want to demonstrate the importance of cathepsin X (CTSX), a cysteine protease, for the Hp eradication success. The diversity of the innate immune response to H. pylori antigens leading to either successful eradication of the infection or maintenance of chronic inflammation is connected to CTSX. The aim of this study is to determine whether H. pylori suppresses the CTSX expression and cytokine secretion in macrophage cell line THP-1 in the individuals that are not capable of eradicating the infection, opposite to H pylori in patients with successful H pylori eradication . The investigators also investigate the possibility whether strain-dependent differences in H. pylori lipopolysaccharide (LPS) influence the CTSX expression and cytokine secretion.